A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

BACKGROUND: The severe acute respiratory syndrome (SARS) virus is a member of the Coronaviridae (CoV) family that first appeared in the Guangdong Province of China in 2002 and was recognized as an emerging infectious disease in March 2003. Over 8000 cases and 900 deaths occurred during the epidemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Julie E., Louder, Mark K., Holman, LaSonji A., Gordon, Ingelise J., Enama, Mary E., Larkin, Brenda D., Andrews, Charla A., Vogel, Leatrice, Koup, Richard A., Roederer, Mario, Bailer, Robert T., Gomez, Phillip L., Nason, Martha, Mascola, John R., Nabel, Gary J., Graham, Barney S.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Science 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612543/
https://www.ncbi.nlm.nih.gov/pubmed/18824060
http://dx.doi.org/10.1016/j.vaccine.2008.09.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612543/
https://www.ncbi.nlm.nih.gov/pubmed/18824060
http://dx.doi.org/10.1016/j.vaccine.2008.09.026

Ejemplares similares